» Articles » PMID: 28152279

Pulmonary Vein Stenosis of Ex-premature Infants with Pulmonary Hypertension and Bronchopulmonary Dysplasia, Epidemiology, and Survival from a Multicenter Cohort

Abstract

Background: Pulmonary vein stenosis is emerging as an important clinical problem in ex-premature infants.

Methods: We sought to describe the epidemiology of pulmonary vein stenosis affecting ex-premature infants by a multicenter retrospective cohort study of patients from seven children's hospitals diagnosed between 2000-2014.

Results: We identified 39 ex-premature patients (26 males, median gestational age 28 weeks range 22-36 weeks, birth weight 1.1 kg range 433-2645-g) with pulmonary vein stenosis. Median age at diagnosis was 6.5 months (1 month-6 years). Presentation with pulmonary hypertension occurred in 26/39 (67%) and 29/39 (74%) had bronchopulmonary dysplasia, 15 (39%) were born of twin pregnancies with unaffected twin siblings. A median of 5 (range 1-25) echocardiograms was performed prior to diagnosis. The diagnosis was made using echocardiography in 22/39 (56%), by multi-detector contrast computed tomography scan (CT) in 8/39 (21%), cardiac catheterization in 6/39 (15%) patients, magnetic resonance imaging in 3/39 (8%). Freedom from death or re-stenosis was 73% at 1-year, 55% at 2, 5, and 10 years. Factors associated with shorter survival or re-stenosis were stenosis of  ≥3 pulmonary veins (P < 0.01), bilateral pulmonary vein stenosis (P < 0.01) small for gestational age (P = 0.05), aged <6 months at diagnosis (P < 0.01).

Conclusion: Pulmonary vein stenosis of ex-premature infants is a complex problem with poor survival, delayed diagnosis, and unsatisfactory treatment. The lack of concordance in twins suggests epigenetic or environmental factors may play a role in the development of pulmonary vein stenosis. In ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia a focused echocardiographic assessment of the pulmonary veins is required with further imaging if the echocardiogram is inconclusive.

Citing Articles

Incidence and Risk Factors of Pulmonary Vein Stenosis After Orthotopic Heart Transplantation in Pediatric Patients.

Takajo D, Critser P, Mantell B, Hirsch R Pediatr Cardiol. 2025; .

PMID: 40056188 DOI: 10.1007/s00246-025-03828-2.


Outcomes of infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension who required home ventilation.

Akangire G, Manimtim W, Agarwal A, Alexiou S, Aoyama B, Austin E Pediatr Res. 2024; 97(1):387-394.

PMID: 39181986 DOI: 10.1038/s41390-024-03495-8.


An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease.

Varghese N, Austin E, Galambos C, Mullen M, Yung D, Guillerman R Eur Respir J. 2024; 64(3).

PMID: 39147412 PMC: 11424926. DOI: 10.1183/13993003.00639-2024.


Management of Pediatric Pulmonary Vein Stenosis.

Callahan R, Morray B, Hirsch R, Petit C J Soc Cardiovasc Angiogr Interv. 2024; 1(5):100391.

PMID: 39131478 PMC: 11307749. DOI: 10.1016/j.jscai.2022.100391.


Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.

Varghese N, Altit G, Gubichuk M, Siddaiah R J Clin Med. 2024; 13(12).

PMID: 38929946 PMC: 11204350. DOI: 10.3390/jcm13123417.